Guyana vs High income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)

Guyana
99.0%
in 2025
High income (World Bank)
87.0%
in 2025
Guyana rank
1st
High income (World Bank) rank
2nd

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Guyana
  • High income (World Bank)
020406080100200820162025

How they compare

Guyana currently reports 99.0% against 87.0% in High income (World Bank), a difference of 12.0%.

That makes Guyana's figure about 1.1 times High income (World Bank)'s.

The two have swapped places 1 time across 18 shared years of data; in 2008 it was High income (World Bank) ahead.

Guyana ranks 1st and High income (World Bank) ranks 2nd of 194 countries.

Across the 3 decades both report, Guyana averaged higher in 2 and High income (World Bank) in 1.

Head to head by decade

Decade Guyana High income (World Bank) Difference Ahead
2000s 0.0% 38.5% 38.5% High income (World Bank)
2010s 80.5% 73.3% 7.2% Guyana
2020s 96.2% 87.3% 8.8% Guyana

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Guyana or High income (World Bank)?
Guyana, at 99.0% against 87.0% in High income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Guyana and High income (World Bank)?
12.0%, with Guyana ahead.
How many years of comparable data are there for Guyana and High income (World Bank)?
18 years are reported by both, from 2008 to 2025.
How do Guyana and High income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Guyana ranks 1st and High income (World Bank) ranks 2nd of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Guyana vs High income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 30 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/guyana/high-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/guyana/high-income-world-bank/">Guyana vs High income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed